We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

45 hedge funds and large institutions have $19.4M invested in Abeona Therapeutics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 10

0% more funds holding

Funds holding: 45 → 45 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

25% less capital invested

Capital invested by funds: $26M → $19.4M (-$6.62M)

Holders
45
Holders Change
–
Holders Change %
0%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
13
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
+$203K
2
SM
Sabby Management
Florida
+$90.3K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$71.7K
4
BFA
BlackRock Fund Advisors
California
+$62.8K
5
SG Americas Securities
SG Americas Securities
New York
+$43K

Top Sellers

Rank Fund Capital Flow
1
GP
GLG Partners
United Kingdom
-$434K
2
SFM
Sphera Funds Management
Israel
-$350K
3
NI
Numeric Investors
Massachusetts
-$72K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$44K
5
IA
IFP Advisors
Florida
-$39.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$4.51M – – –
SFM
2
Soros Fund Management
New York
$3.74M – – –
KCM
3
Knoll Capital Management
Florida
$3.48M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.44M +$71.7K +1,083 +5%
SFM
5
Sphera Funds Management
Israel
$1.2M -$350K -5,278 -22%
RA
6
Royce & Associates
New York
$963K +$203K +3,067 +26%
SM
7
Sabby Management
Florida
$855K +$90.3K +1,364 +11%
BFA
8
BlackRock Fund Advisors
California
$774K +$62.8K +949 +9%
DCM
9
DAFNA Capital Management
California
$465K – – –
BIT
10
BlackRock Institutional Trust
California
$361K -$4.11K -62 -1%
Northern Trust
11
Northern Trust
Illinois
$268K +$464 +7 +0.2%
CT
12
Cambridge Trust
Massachusetts
$167K – – –
State Street
13
State Street
Massachusetts
$162K -$4.11K -62 -2%
BIM
14
BlackRock Investment Management
Delaware
$116K +$2.32K +35 +2%
TCIM
15
TIAA CREF Investment Management
New York
$104K – – –
PCM
16
Prelude Capital Management
New York
$91K +$14.3K +216 +18%
IA
17
IFP Advisors
Florida
$74K -$39.7K -600 -60%
KA
18
KLCM Advisors
Wisconsin
$73K – – –
California State Teachers Retirement System (CalSTRS)
19
California State Teachers Retirement System (CalSTRS)
California
$62K +$8.81K +133 +16%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$53K +$5.1K +77 +10%
TA
21
Teachers Advisors
New York
$51K – – –
SG Americas Securities
22
SG Americas Securities
New York
$42K +$43K +650 New
AllianceBernstein
23
AllianceBernstein
Tennessee
$40K – – –
Charles Schwab
24
Charles Schwab
California
$38K – – –
Goldman Sachs
25
Goldman Sachs
New York
$31K -$26.8K -404 -45%
1
2

ABEO Hedge Fund Activity: Q1 2016 in Review

45 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2016, worth a combined $19.4M — down 25% from $26M a quarter earlier.

Fund positioning in ABEO was balanced in Q1 2016: 4 funds opened new positions, 4 closed out, 13 added to existing stakes and 10 trimmed.

The largest buyer was Royce & Associates, adding an estimated $203K. The largest seller was GLG Partners, exiting entirely with an estimated $434K sold.

  • 45 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2016, unchanged from Q4 2015.
  • Funds reported $19.4M of Abeona Therapeutics stock for Q1 2016, down 25% quarter-over-quarter.
  • 4 funds opened new Abeona Therapeutics positions in Q1 2016 and 4 closed out, a net change of 0 holders.
  • The largest Abeona Therapeutics buyer in Q1 2016 was Royce & Associates, an estimated $203K added.
  • The largest Abeona Therapeutics seller in Q1 2016 was GLG Partners, an estimated $434K sold.

Based on aggregated 13F filings for Q1 2016.